|
YAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.945440E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.922300E-02 |
| Normal-vs-Stage2 |
4.791800E-01 |
| Normal-vs-Stage3 |
8.135200E-01 |
| Normal-vs-Stage4 |
4.504800E-01 |
| Stage1-vs-Stage2 |
5.983800E-01 |
| Stage1-vs-Stage3 |
8.442300E-02 |
| Stage1-vs-Stage4 |
7.155200E-03 |
| Stage2-vs-Stage3 |
5.849400E-01 |
| Stage2-vs-Stage4 |
2.118600E-01 |
| Stage3-vs-Stage4 |
3.352000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.295800E-01 |
| Normal-vs-AfricanAmerican |
1.076760E-01 |
| Normal-vs-Asian |
2.819000E-01 |
| Caucasian-vs-AfricanAmerican |
3.694000E-01 |
| Caucasian-vs-Asian |
7.947400E-01 |
| AfricanAmerican-vs-Asian |
5.377400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.596400E-01 |
| Normal-vs-Female |
7.613600E-02 |
| Male-vs-Female |
3.263800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.908400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.017800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.080000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.103800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.979760E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.819400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.454610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.376800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.425000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.865000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.122100E-02 |
| Classical-VS-Follicular |
1.724160E-02 |
| Classical-VS-Other |
2.767800E-01 |
| Classical-VS-Normal |
2.720300E-02 |
| Tall-VS-Follicular |
9.799000E-01 |
| Tall-VS-Other |
7.635000E-01 |
| Tall-VS-Normal |
8.451200E-01 |
| Follicular-VS-Other |
8.111200E-01 |
| Follicular-VS-Normal |
8.566600E-01 |
| Other-VS-Normal |
6.704400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.521200E-01 |
| Normal-vs-N1 |
7.513400E-01 |
| N0-vs-N1 |
4.306400E-01 |
|
|
